Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies

Vitiligo is a dermatological condition affecting 1% of the global population, characterized by the loss of skin pigmentation. It appears in two main forms: nonsegmental (symmetrical depigmentation) and segmental (localized depigmentation). Oxidative stress and mitochondrial dysfunction in melanocyte...

Full description

Saved in:
Bibliographic Details
Main Authors: Artur Kovenskiy, Nurlubek Katkenov, Zhussipbek Mukatayev, Almagul Kushugulova
Format: Article
Language:English
Published: National Scientific Medical Center 2024-12-01
Series:Ķazaķstannyṇ Klinikalyķ Medicinasy
Subjects:
Online Access:https://www.clinmedkaz.org/download/unraveling-vitiligo-from-immune-mechanisms-to-promising-therapeutic-strategies-15715.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846100120735580160
author Artur Kovenskiy
Nurlubek Katkenov
Zhussipbek Mukatayev
Almagul Kushugulova
author_facet Artur Kovenskiy
Nurlubek Katkenov
Zhussipbek Mukatayev
Almagul Kushugulova
author_sort Artur Kovenskiy
collection DOAJ
description Vitiligo is a dermatological condition affecting 1% of the global population, characterized by the loss of skin pigmentation. It appears in two main forms: nonsegmental (symmetrical depigmentation) and segmental (localized depigmentation). Oxidative stress and mitochondrial dysfunction in melanocytes cause vitiligo, while immune privilege protects hair follicle melanocytes, allowing for possible repigmentation. Genetic factors and associations with other autoimmune diseases, such as type 1 diabetes and thyroiditis, suggest a heritable autoimmune component. CD8+ T cells play a crucial role in vitiligo, targeting melanocytes and promoting apoptosis. These cells, along with IFN-γ signaling, contribute to disease progression. Therapies targeting these pathways, such as JAK inhibitors, have shown promise in repigmentation, particularly when combined with narrowband UVB phototherapy, a gold standard treatment. Surgical interventions, including punch grafting and suction blister grafting, show high efficiency but bring high risks of skin damage and hyperpigmentation. Vitiligo patients experience significant emotional suffering, requiring both a psychological and medical treatment approach. Dietary interventions, specifically those rich in antioxidants, may support disease treatment. Vitamin D, in particular, is a promising therapeutic agent by protecting melanocytes from oxidative stress via the WNT/β-catenin pathway. This review points out the need for more research on targeted therapies that combine immune regulation, phototherapy, and dietary strategies for effective vitiligo treatment.
format Article
id doaj-art-a42c7bb4d9b64de98f6c1c0fd52b5988
institution Kabale University
issn 1812-2892
2313-1519
language English
publishDate 2024-12-01
publisher National Scientific Medical Center
record_format Article
series Ķazaķstannyṇ Klinikalyķ Medicinasy
spelling doaj-art-a42c7bb4d9b64de98f6c1c0fd52b59882024-12-30T16:30:26ZengNational Scientific Medical CenterĶazaķstannyṇ Klinikalyķ Medicinasy1812-28922313-15192024-12-01216182310.23950/jcmk/15715Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic StrategiesArtur Kovenskiy0Nurlubek Katkenov1Zhussipbek Mukatayev2Almagul Kushugulova3National Laboratory Astana, Nazarbayev University, Astana, KazakhstanNational Laboratory Astana, Nazarbayev University, Astana, KazakhstanNational Laboratory Astana, Nazarbayev University, Astana, KazakhstanNational Laboratory Astana, Nazarbayev University, Astana, KazakhstanVitiligo is a dermatological condition affecting 1% of the global population, characterized by the loss of skin pigmentation. It appears in two main forms: nonsegmental (symmetrical depigmentation) and segmental (localized depigmentation). Oxidative stress and mitochondrial dysfunction in melanocytes cause vitiligo, while immune privilege protects hair follicle melanocytes, allowing for possible repigmentation. Genetic factors and associations with other autoimmune diseases, such as type 1 diabetes and thyroiditis, suggest a heritable autoimmune component. CD8+ T cells play a crucial role in vitiligo, targeting melanocytes and promoting apoptosis. These cells, along with IFN-γ signaling, contribute to disease progression. Therapies targeting these pathways, such as JAK inhibitors, have shown promise in repigmentation, particularly when combined with narrowband UVB phototherapy, a gold standard treatment. Surgical interventions, including punch grafting and suction blister grafting, show high efficiency but bring high risks of skin damage and hyperpigmentation. Vitiligo patients experience significant emotional suffering, requiring both a psychological and medical treatment approach. Dietary interventions, specifically those rich in antioxidants, may support disease treatment. Vitamin D, in particular, is a promising therapeutic agent by protecting melanocytes from oxidative stress via the WNT/β-catenin pathway. This review points out the need for more research on targeted therapies that combine immune regulation, phototherapy, and dietary strategies for effective vitiligo treatment.https://www.clinmedkaz.org/download/unraveling-vitiligo-from-immune-mechanisms-to-promising-therapeutic-strategies-15715.pdfvitiligointerferon gammamelanocytejanus kinases
spellingShingle Artur Kovenskiy
Nurlubek Katkenov
Zhussipbek Mukatayev
Almagul Kushugulova
Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
Ķazaķstannyṇ Klinikalyķ Medicinasy
vitiligo
interferon gamma
melanocyte
janus kinases
title Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
title_full Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
title_fullStr Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
title_full_unstemmed Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
title_short Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
title_sort unraveling vitiligo from immune mechanisms to promising therapeutic strategies
topic vitiligo
interferon gamma
melanocyte
janus kinases
url https://www.clinmedkaz.org/download/unraveling-vitiligo-from-immune-mechanisms-to-promising-therapeutic-strategies-15715.pdf
work_keys_str_mv AT arturkovenskiy unravelingvitiligofromimmunemechanismstopromisingtherapeuticstrategies
AT nurlubekkatkenov unravelingvitiligofromimmunemechanismstopromisingtherapeuticstrategies
AT zhussipbekmukatayev unravelingvitiligofromimmunemechanismstopromisingtherapeuticstrategies
AT almagulkushugulova unravelingvitiligofromimmunemechanismstopromisingtherapeuticstrategies